New peptide shot could get athletes back on field faster after hamstring pull
NCT ID NCT07437547
First seen Mar 07, 2026 · Last updated May 07, 2026 · Updated 7 times
Summary
This study tests an investigational peptide called BPC 157 to see if it can help heal a moderate hamstring muscle tear faster than standard rehab alone. About 120 adults aged 18 to 45 with a recent, MRI-confirmed grade II hamstring strain will receive either BPC 157 or a placebo for 14 days, plus a structured rehab program. The main goals are how quickly they can return to full sport and how much the muscle injury shrinks on MRI at two weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAMSTRING MUSCLE STRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518036, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.